JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266385

Human NRD1 (Nardilysin) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

NRDC KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
1 Images
Sanger Sequencing - Human NRD1 (Nardilysin) knockout HEK-293T cell line (AB266385)
  • Sanger seq

Unknown

Sanger Sequencing - Human NRD1 (Nardilysin) knockout HEK-293T cell line (AB266385)

Homozygous : Insertion of the selection cassette in exon2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266385-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266385 Human NRD1 (Nardilysin) knockout HEK-293T cell line", "number":"AB266385-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266385-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266385-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266385-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266385 Human NRD1 (Nardilysin) knockout HEK-293T cell line", "number":"AB266385-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266385-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266385 Human NRD1 (Nardilysin) knockout HEK-293T cell line", "number":"AB266385-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266385-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266385 Human NRD1 (Nardilysin) knockout HEK-293T cell line", "number":"AB266385-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
NRDC
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Nardilysin also referred to as NRD1 is a metalloendopeptidase that plays a role in protein processing. It possesses a molecular weight of approximately 124 kDa. Nardilysin is part of the M16 family of peptidases and is located predominantly in the cytoplasm but can also be found in the cell nucleus. The protein exhibits expression in a wide range of tissues indicating its widespread functional importance.
Biological function summary

Nardilysin impacts several cellular processes due to its role in cleaving specific peptides. It serves as a modulator of protein-protein interactions and is involved in the regulation of cell proliferation and differentiation. Nardilysin participates in the processing of various bioactive peptides and proteins and can function as part of a protein complex in some contexts. Its regulatory activities suggest its important role in maintaining cellular function and integrity.

Pathways

Nardilysin is involved in the promotion of the fibroblast growth factor (FGF) pathway and the insulin-like growth factor (IGF) signaling pathway. In these pathways it interacts with other proteins such as FGF receptors and IGF-binding proteins influencing cellular growth signaling and metabolic regulation. Nardilysin's involvement highlights its capacity to modulate key biological processes which are essential for normal cellular responses.

Nardilysin is linked with neurological disorders such as Alzheimer's disease where it is known to interact with amyloid precursor protein (APP) which plays a significant role in the disease's pathogenesis. Moreover its dysregulation has associations with metabolic disorders like obesity impacting proteins such as leptin and affecting energy balance. These associations emphasize the clinical significance of nardilysin as a potential target for therapeutic intervention.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com